Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2026-04-11 @ 11:25 PM
Study NCT ID:
NCT01021150
Status:
COMPLETED
Last Update Posted:
2011-06-13
First Post:
2009-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TCD11088
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Trial Transparency Team
Old Organization:
sanofi-aventis